Agenda/Syllabus

Thursday

Nov 1, 2018

7am: Complimentary Breakfast
8am – 12pm: Conference Sessions
12pm: Complimentary Lunch
1:30pm – 5:30pm: Conference Sessions
5:30pm – 7pm: AMMG Welcome Reception

Friday

Nov 2, 2018

7am: Complimentary Breakfast
8am – 12pm: Conference Sessions
12pm: Complimentary Lunch
1:30pm – 5:30pm: Conference Sessions
5:30pm: Reception introducing Training & Certification

Saturday

Nov 3, 2018

7am: Complimentary Breakfast
8am – 12pm: Conference Sessions
12pm: Complimentary Lunch
1:30pm – 5:30pm: Conference Sessions
5:30pm – 6:30pm: Meet Dr. Wright

Sunday

Nov 4, 2018

7am: Complimentary Breakfast
8am – 11:30am: Panel Sessions – Submit your cases
11am: Break
11:30am – 1:30pm: Conference Sessions

Pre-Conference Track 1

Clinical Use of Peptides and Peptide Therapies

The use of Peptides and Peptide Therapies has experienced exponential growth over the past few years. Their uses range from impacting hormonal change, to antibiotic properties, to treatments for conditions of aging such as cancer, cardiovascular health, memory & brain health and sexual function. AMMG’s educational mandate is to fill knowledge gaps, and our attendees have indicated that a focused track on peptides is essential to educate members and attendees on the science and clinical uses of peptides in an age management practice.

Time
Presentation
7:00 am – 7:45 am How to Treat Adult Growth Hormone Deficiency
Mark L. Gordon, M.D.
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by University Compounding Pharmacy
8:00 am – 8:20 am Introduction to Peptides
Edwin N. Lee, M.D., FACE
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
The world of peptides therapy is a growing field in medicine ranging from improving skin care, growth hormone, to one’s immune system, to name a few. On PubMed there are over 2.5 million articles on peptides. It is estimated that humans have over 250,000 peptides and we only understand a fraction of them. Peptides are chains of amino acids linked together by a polypeptide bond. The formation of a polypeptide bond by a dehydration synthesis will be reviewed. The difference of a peptide versus a protein will be delineated. In addition the mechanism of action on how peptides work will be reviewed.
8:20 am – 9:20 am BPC-157 for Healing Gastric Ulcers and Superior Healing of Tendinopathies
Rob Kominiarek, D.O., FACOFP 
Director, ReNue Health, Springboro, OH
Assistant Clinical Professor, Ohio University College of Osteopathic Medicine
Peptides—you have heard of them, but how and when do you use them? These simple short chains of amino acids regulate almost every known system and process in the body to include hormone production. In this lecture you will discover some of the uses of BPC-157. Pentadecapeptide BPC 157, composed of 15 amino acids, is a partial sequence of body protection compound that was discovered in and isolated from human gastric juice. Experimentally it has been demonstrated to accelerate the healing of many different wounds, including tendon to bone healing and healing of damaged ligaments. Additionally, BPC 157 seems to protect organs and to heal and prevent ulcers of the stomach. This peptide has also been demonstrated to reduce pain in areas of damaged tissue, mitigating the need for narcotic type medications. Individuals who are suffering from muscle sprains, tears, and damage can benefit from treatment with this unique peptide.
9:20 am – 10:15 am Brain Health with Cerbolysin and other Peptides
Kathy O’Neil-Smith, M.D., FAARM
Private Internal, Integrative and Regenerative Medicine Practice, Newton, MA
Brain health is an important consideration for health and well-being. To date, drugs targeting a single pathological pathway have failed to show clinical efficacy for concussions, TBI, memory loss and dementia. Nootropic peptides are pleiotropic agents with effects on multiple mechanisms of brain injury that are an effective option to improve brain recovery and clinical outcome for restoring brain health.
10:15 am – 10:30 am Break
10:30 am – 11:15 am Peptides to Increase Growth Hormone (CJC 1295, Ipamorelin, Tesamorelin, GHRP-6 and Others)
Edwin N. Lee, M.D., FACE
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
Growth hormone is an essential hormone in lowering body fat, improving on lipids, keeping muscles healthy and improving on bone density. Adult growth hormone deficiency symptoms will be reviewed and the association of higher mortality with growth hormone deficiency. Unfortunately the treatment with recombinant human growth hormone is not covered under most insurance plans and it is also cost prohibitive for most people. There is an alternative to the expensive recombinant human growth hormone mostly commonly used for boosting IGF-1 and has the advantage of inducing all five of the hGH isoforms rather just the one that is found in the synthetic form. CJC-1295, Ipamorelin, GHRP-6, Teslomorelin and others are peptides that have been shown to help improve IGF-1 levels.
11:15 am – 12:00 pm Peptides for Sleep, Improving Telomeres, Libido, Reproduction and Memory
Edwin N. Lee, M.D., FACE
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
It is estimated that there are about 250,000 peptides in the human body. We only understand a fraction of all the peptides. This talk will cover a wide range of issues. Delta Sleep Induced Peptide can help with restoring sleep. Epithalon is a peptide discovered by a famous Russia scientist Dr Khavinson. He has published extensively since the 1970’s and has published the longest human study on epithalon improving longevity and also increasing telomere lengths. A new drug is being developed to help with sexual dysfunction. This drug is the peptide Bremelanotide PT 141. The love peptide hormone kisspeptin will be reviewed. In addition Semax will be discussed to help with memory.
12:00 pm – 1:30 pm Lunch Break
12:00 pm – 1:00 pm  NeuroRegenesis: Treating Memory Loss and the Aging Brain
A.J. Farshchian, M.D.
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Center for Regenerative Medicine
1:30 pm – 2:15 pm Peptides for Cancer
Luis Martínez, M.D., MPH
President, Regenera Global, Ponce, Puerto Rico
President, XanoGene Clinic, San Juan, Puerto Rico
Recent advances in peptide biology have found multiple peptides capable of exerting therapeutic benefits in the treatment of cancer. This lecture will discuss peptide classes, mechanisms of action and proposed protocols for incorporating peptide therapy in the treatment of cancer patients.
2:15 pm – 3:00 pm Thymosin Peptides – Part 1Part 2Part 3Part 4
Kathy O’Neil-Smith, M.D., FAARM
Private Internal, Integrative and Regenerative Medicine Practice, Newton, MA
Thymosins have been recognized as key peptides that help to regulate our immune system. As biological response modifiers, they are now being used in the treatment of disease with significant results and promise. These “new medicines”, based on discoveries in the areas of host immunity and regenerative medicine, have provided clinicians with additional treatment options in the treatment of autoimmune and infectious diseases. The thymosins can synergize with supplements and conventional therapies, increasing the effectiveness of the treatment protocol.
2:30 pm Exhibits Open
3:00 pm – 3:45 pm Break / Visit Exhibits
3:45 pm – 4:30 pm Peptides for Autoimmune Disease
Luis Martínez, M.D., MPH
President, Regenera Global, Ponce, Puerto Rico
President, XanoGene Clinic, San Juan, Puerto Rico
Immune dysregulation, a universal characteristic of autoimmune diseases, can be targeted through the use of specific peptides. This lecture will present the rationale for utilizing peptide therapy in the management of autoimmune diseases. T-cell modulation, OGF axis and other mechanisms of action will be highlighted. Cases and protocols will be discussed.
4:30 pm  – 4:50 pm Protecting Yourself in Age Management Medicine
Rob Kominiarek, D.O., FACOFP 
Director, ReNue Health, Springboro, OH
Assistant Clinical Professor, Ohio University College of Osteopathic Medicine
Murderers, Rapists, and Terrorists have rights, but physicians do not! You are guilty and you can not prove your innocence. The facts are, a doctor can have a license sanctioned, suspended, revoked, limited, be bankrupted, disgraced, and made unemployable, based on an anonymous complaint that might have come from a disgruntled employee, a jealous competitor, an insurance company that doesn’t want to pay a bill, or a drug addict who wants a lighter sentence. And you have no right to know who the accuser is or even what you are being accused of committing. Board employees function as investigator, prosecutor, judge, jury, and executioner. The politically appointed members of the board almost always rubber-stamp what the board staff wants. The staff generally controls the flow of information to board members and accused doctors. The doctor has no right to cross-examine accusers, to ask that conflicted or biased staff be recused, or to challenge the evidence against him or her, which he might not even have seen. In short, modern day medical boards are the equivalent of medieval Consiglio dei Dieci only falling short by not being able to send you to the Judas Cradle. So how do you protect yourself? In this lecture we will explore the many avenues you can approach to provide as much protection as you can for your hard earned medical license.
4:50 pm – 5:30 pm Panel with Q & A
Edwin N. Lee, M.D., FACE
Kathy O’Neil-Smith, M.D., FAARM
Rob Kominiarek, D.O., FACOFP 
Luis Martínez, M.D., MPH
5:30 pm – 7:00 pm AMMG Welcome Reception
Open to all conference attendees, spouses, and guests
Held in Conference Networking and Exhibits Center

Pre-Conference Track 2

Novel Clinical Interventions in Age Management Medicine

Track is designed to present an array of new and innovative clinical interventions for the Age Management Medicine clinician. These interventions are designed so that the attendee can take them back to their practice and begin to implement them immediately.

Time
Presentation
7:00 am – 7:45 am How to Treat Adult Growth Hormone Deficiency
Mark L. Gordon, M.D.
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by University Compounding Pharmacy
8:00 am – 9:00 am Benefits of Cannabis on the Brain’s Endocannabinoid Receptors
Deepa B. Verma, M.D., AIHM
Founder & Owner, Synergistiq Integrative Health, Clearwater, FL
There are two active chemicals in marijuana that research has shown may be helpful in brain awaking. Cannabidiol (CBD) and tetrahydrocannabinol (THC) and other biologically active cannabinoids have been studied. Research has shown that the cannabinoid system develops through childhood and then gradually declines as one ages. The endogenous cannabinoid system in the brain works primarily to preserve homeostasis of memory and neuronal activity in the brain, especially in the hippocampus. Cannabinoids are shown to slow down age-related decline in cognition and dementia, while having a host of other beneficial effects that can be used in the treatment of pain, glaucoma, cancer and more. Scientific research has shown cannabis to have the following properties: anti-emetic, anti-anxiolytic, anti-carcinogenic, anti-convulsant, anti-psychotic, anti-inflammatory and anti-oxidative.
9:00 am – 10:00 am Mycotoxins – The Secret Masquerader: Is it Lyme Disease or Mycotoxins? How to Differentiate, Diagnose and Treat
Andrew W. Campbell, M.D. 
Editor-in-Chief, Alternative Therapies in Health and Medicine Medical Journal & Advances in Mind-Body Medicine Journal
Editorial Board, Integrative Medicine: A Clinician’s Journal
Medical Editor, Natural Solutions and Alternative Medicine Magazines
This evidence-based lecture reviews the similarities and differences between patients suffering from Lyme disease and mycotoxicosis. It will cover how to differentiate, diagnose and treat mycotoxicosis vs. Lyme disease, and what are the best tests to order to help in diagnosing whether a patient has been affected by Lyme or mycotoxins, followed by a section on treatment, including supplements and probiotics.
10:00 am – 10:15 am Break
10:15 am – 11:15 am Obtaining Proper Growth Hormone Lab Levels & New Safety Information Regarding HGH
What HGH Research Has Taught Us
Dan C. Purser, D.C., M.D. 
Medical Director / Physician, Clinical Practice, Provo, UT
Research Assistant to Nabil Gemayel, M.D. (Pituitary Endocrinology and Cardiology) USC Keck School of Medicine
President, Professional Nutraceutical Design
Dr. Dan Purser starts with the basics – how to obtain a proper IGF-1 level. These tips are not known and should be, so more accurate and effective IGF-1 levels can be obtained. He will cover the prescription drugs that should be temporarily held (Provigil, Nuvigil, Zoloft, Cymbalta, Lyrica, Effexor, etc.) prior to the blood draw because they can and do massively and falsely increase IGF-1 levels, giving false results. Dr. Purser will teach that overnight (water allowed) fasting is critical to getting an accurate level of IGF-1, and why. Also, he will cover why the level needs to be in the AM and no exercise allowed prior to the level being drawn. Dr. Purser will also explain why you may have to wait and watch in younger adults or teens when you suspect damage to the anterior pituitary, sometimes for months or years. Also, he’ll teach that HGH production is the first thing usually harmed when a TBI or head injury or suspected pituitary dysfunction has occurred. Dr. Purser also covers other tricks and concepts of HGH levels and goes into what only a few of the most knowledgeable pituitary endocrinologists in the country know.
11:15 am – 12:00 pm InflammAging: Bacterial Toxins and Systemic Inflammation
Mark Engelman, M.D., FSCM 
Founder, Engelman Health Institute, Phoenix, AZ
Intestinal bacterial endotoxins lipopolysaccharides (LPS) and cytolethal distending toxin B (CdtB), are released by gram-negative bacteria in the intestinal tract and elicit strong immune responses in humans. Researchers are elucidating the pathogenic bacterial toxins play in disorders of the gut, lung, liver, joints and thyroid as well as nervous, immune and endocrine systems. When searching for environmental triggers of chronic health problems, which significantly decrease quality of life and accelerate the aging process, assessing systemic bacterial toxins should be at the top of the list. With a simple serum assessment, this cost-effective test can elucidate the possible cause of systemic inflammation that contributes to a variety of disorders. Clearly more attention should be paid to intestinal barrier function and antigenic permeability that can lead to bacterial toxin-induced systemic inflammation. This presentation will highlight key studies about systemic bacterial toxins, how to expertly assess systemic bacterial toxins and barrier permeability as well as treatment protocols for healing body barriers.
12:00 pm – 1:30 pm Lunch Break
12:00 pm – 1:00 pm  NeuroRegenesis: Treating Memory Loss and the Aging Brain
A.J. Farshchian, M.D.
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Center for Regenerative Medicine
1:30 pm – 2:15 pm Fast-Mimicking Diets – A Novel Therapy to Combat the Relentless Effects of Aging
Felice Gersh, M.D.
Director, Integrative Medical Group of Irvine, Irvine, CA
It’s now recognized that aging is characterized by the development of chronic, unrelenting inflammation, which drives the varied metabolic medical problems endemic to aging individuals, including varied cancers, obesity, insulin resistance, hypertension, cardiovascular disease and dementia. Lowering inflammation is a daunting task. Fasting has been shown to lower systemic inflammation and also to modify the critically important microbial makeup of the gut, thereby impacting all aspects of metabolic well-being. Additional beneficial effects occur with the use of fast-mimicking diets – which allows one to eat while the body perceives fasting. This makes “fasting” both doable for the average patient, and far safer than is water fasting. Additional benefits include the activation of processes which rejuvenate cells (autophagy), promotion of beneficial programmed cell suicide (apoptosis), increases in brain derived neurotrophic factor, and the stimulation of stem cells. This presentation will introduce a novel and effective means to improve the health of aging individuals through the implementation of periodic fasting, by utilizing the unique fast-mimicking diet developed at the Longevity Institute at the University of Southern California.
2:15 pm – 3:00 pm Clinical Interventions for Thyroid and Adrenal Dysfunction
John K. Crisler, D.O.
President, Founder & CMO, Superior Age Management, AllThingsMale Center for Men’s Health, Lansing, MI
Dept. of Community & Family Medicine, Michigan State University College of Osteopathic Medicine, East Lansing, MI
Because thyroid hormone’s effects are as hand-in-glove with the adrenal hormone cortisol, these two hormones are discussed together. Diagnosing subclinical hypothyroidism often requires more focus upon patient subjective report while interpreting labwork and subsequent clinical decision making. As it takes cortisol to then get the thyroid hormone into the cells, and these patients often have endured long periods of hormonal imbalance, stress, fatigue and nutritional deficiency, adrenal function must be kept in mind. Here we will explore the “myth” of Adrenal Fatigue.
2:30 pm Exhibits Open
3:00 pm – 3:40 pm Break / Visit Exhibits
3:40 pm – 4:35 pm Intermittent Fasting, Carb Cycling & Weight Management
Brent Agin, M.D.
Physician / Owner, Metabolix Wellness Center, Clearwater, FL
Medical Director, Novus Medical Detox, Tampa Bay & West Palm Beach, FL
In this segment, Dr. Agin will discuss three of his five key “pillars of health” that must be in place for optimal well-being: diet, nutrition and exercise. He will discuss the positive effects of ketosis on hormones, body fat and disease treatment and prevention. He will look at intermittent fasting as an alternative to low carbohydrate, ketogenic diet programs for fat loss and other health benefits. See why carb cycling can provide the macronutrient balance which is the key for success in all diet programs. Provide an overview of other wellness modalities beyond dieting to enhance metabolism and keep patients feeling well and engaged in maximizing their health
4:35 pm – 5:30 pm Interventions for Sexual Dysfunction in Men
Kathryn Retzler, N.D.
HormoneSynergy Clinic LLC, Portland, OR
This lecture will cover sexual dysfunction in men, diagnostic tools including history taking, lab work, and validated questionnaires, and a thorough discussion of treatment options. Emphasis will be placed on a holistic approach to treat underlying causes and achieve optimal outcome.
5:30 pm – 7:00 pm AMMG Welcome Reception
Open to all conference attendees, spouses, and guests
Held in Conference Networking and Exhibits Center

Pre-Conference Track 3

Office Based Aesthetics for the Age Management Clinician*

In response to attendee requests for information on aesthetic protocols and treatments which are office based and can be done by non-board certified Age Management Clinicians either full time or as an adjunct to their existing practice, AMMG presents this track in conjunction with the Advanced Aesthetic Education Group. The decision not to accredit this track was made so that attendees could be provided with business tools as well as the science and medical information necessary to implement these procedures. The goal is not to make this track commercial but to give speakers in this niche area the leverage to openly discuss procedures and answer questions that could be severely restricted in an accredited environment.

In conjunction with the Advanced Aesthetic Education Group
* Track is Non-CME

Time
Presentation
7:00 am – 7:45 am How to Treat Adult Growth Hormone Deficiency
Mark L. Gordon, M.D.
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by University Compounding Pharmacy
8:00 am – 8:45 am PDO Thread Lifting
H. William Song, M.D.
Founder & CEO, Omni Aesthetics, Oakland, NJ
Clinical observation showed that PDO (polydioxanone) threads increase the synthesis of endogenous hyaluronic acid and improves local microcirculation. In short, it stimulates production of new collagen protein which results in increased elasticity and firmness of the skin. Bio-stimulation is a new approach that can lift the face, neck and body. Insertion of the powerful synthetic fiber, consisting of a smooth lament, which is absorbed in the tissue leaves the skin firmer, more elastic and better hydrated.
8:45 am – 9:30 am Aesthetic Treatment Protocols for the Treatment of Rosacea
Marie Piantino, L.E. 
President, Aesthetic Education Group, LLC
Founder, American Academy of Medical Microneedling
Find out what treatments are available for treating rosacea, how to combine them with topical products, prescription and cosmeceutical. Create packages for the patient with creative pricing. Review useful imagining system to record patient improvements; do they have to be costly?
9:30 am – 10:15 am Body Contouring including Different Techniques Freeze/Melt/Lipo and Combining Treatments
H. William Song, M.D.
Founder & CEO, Omni Aesthetics, Oakland, NJ
Review the different ways to use traditional lipo/freeze/melt and acoustic wave; what to choose for the patient and why. What are the costs involved in equipment, staffing and marketing. Different body types and what works best; packages and corresponding pricing.
10:15 am – 10:30 am Break
10:30 am – 11:15 am Reversing The Aging Face – Use of IGF-1 Growth Hormone, Melatonin and Thyroid Gels, Lotions, Sprays and Sublinguals
Richard Lippman, M.D.
Retired Anti-Aging Physician
President, Professional Nutraceutical Design
Nasal sprays, topical gels, sublingual lozenges and sprays, and ear-canal applications are often the preferred forms of hormone correction. They release pharmacokinetically the needed hormones through the skin and into the bloodstream in a gradual steady-state fashion. Consequently, these methods of hormone administration are often superior to injections or bolus administration of oral tablets and capsules. Patients are more likely to be compliant with spraying their daily hormones or supplements rather than consuming them orally or by injection.
11:15 am – 12:00 pm Acne, Inflammatory and Non-Inflammatory Lesions – Causes and Solutions
Sheila Malmanis, L.E.
President, MS Skintechnical, Phoenix, AZ
Discussion of the many facets of acne. Diagnosis of the condition and type of condition, and the relative ways to clinically treat using various protocols that include topicals, equipment or prescriptions.
12:00 pm – 1:30 pm Lunch Break
12:00 pm – 1:00 pm  NeuroRegenesis: Treating Memory Loss and the Aging Brain
A.J. Farshchian, M.D.
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Center for Regenerative Medicine
1:30 pm – 2:30 pm Amniotic Fluid – a New Breakthrough in Aesthetic Medicine
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic, Redlands, CA
Medical Advisor, Rejuvenate Image Restoration, Refine and AQ Skin Solutions
What is the hype around the use of Amniotic Fluid for Aesthetics? This lecture will discuss the advantages of its use, when to use and how. Is it FDA approved? Safe? Where to get it? What to look for?
2:30 pm – 3:15 pm Acoustic Wave Therapy
H. William Song, M.D.
Founder and CEO, Omni Aesthetics, Oakland, NJ
What is acoustic wave therapy and what are the treatment applications, who can use this equipment, what are the different protocols? Protocols for cellulite, pre- and post-care/male enhancement, skin tightening and combination treatments.
2:30 pm Exhibits Open
3:15 pm – 3:45 pm Break / Visit Exhibits
3:45 pm – 4:45 pm Skin Exfoliation – Physical & Machine
Lecture and Demonstration

Marie Piantino, L.E.
President, Aesthetic Education Group, LLC
Founder, American Academy of Medical Microneedling
Understand the many types of exfoliation, peels, microdermabrasion, derma plain and topical products. What conditions could we treat and with what program? What can you combine together successfully to treat which condition, and how would you price the program? Learn the basic and the advanced applications.
4:45 pm – 5:30 pm Hair Restoration – Treating the Scalp
Lecture and Demonstration

Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic, Redlands, CA
Medical Advisor, Rejuvenate Image Restoration, Refine and AQ Skin Solutions
Find out about all the available advancements in the hair restoration field. The use of Growth Factors, PRP, microneedling and transplants. How to diagnose each patient and plan a successful restoration program. This is an exciting emerging field.
5:30 pm – 7:00 pm AMMG Welcome Reception
Open to all conference attendees, spouses, and guests
Held in Conference Networking and Exhibits Center

Pre-Conference Track 4

Traumatic Brain Injury: A Clinical Approach to Diagnosis and Treatment

This full-day program, TBI – A Clinical Approach to Diagnosis and Treatment, will provide to the attendees overwhelming information culled from peer-reviewed articles on Traumatic Brain Injury as the causative factor for personality changes, cognitive impairment and mood disorders leading up to suicide. The attendees will be walked through the literature discussing the effects of primary trauma and the secondary effects of inflammation and oxidative stress on functionality.

In conjunction with the Warrior Angels Foundation, a 501(c)(3) non-profit organization

A portion of the proceeds from this course will be donated to the Warrior Angels Foundation as they work towards their goal of providing personalized assessment and treatment for U.S. Military service members and veterans who have sustained Traumatic Brain Injury (TBI) while in the line of duty.

Course Faculty (all sessions in this track)
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
USC, Keck School of Medicine, Department of Family Medicine, Los Angeles, CA
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
Life Member, AMMG

Time
Presentation
7:00 am – 7:45 am How to Treat Adult Growth Hormone Deficiency
Mark L. Gordon, M.D.
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by University Compounding Pharmacy
8:00 am – 8:30 am An Introduction to Traumatic Brain Injury
A 30-minute overview of trauma, inflammation, and how it impacts the cognitive and emotional functionality of the brain.
8:30 am – 9:30 am Neurology, Neuropathology and Neuroendocrinology in Traumatic Brain Injury
60-minute discussion based upon literature about the specific cellular and biochemical cascades that are initiated by neuro-trauma. Expanding discussion on the indolent and stealth progression of the initial injury (primary) and the years of damage produced by the secondary injury.
9:30 am – 10:15 am The Laboratory of Traumatic Brain Injury
The assessment of neurotrauma using trophic, neurosteroids, and neuroactive steroids as markers for hormonal deficiencies that are caused by both the primary and secondary injuries associated with neurotrauma (TBI). The literature supported view that the “standard reference” ranges and “normal” reference ranges are not relative to the patient. Interpretation of the lab results using the Median Theory of optimal levels.
10:15 am – 10:30 am Break
10:30 am – 11:30 am Traumatic Brain Injury and Neurobehavior
The impact of neurosteroid deficiencies on both personality and mental abilities is clearly discussed in peer-reviewed articles. Those same articles provide support for mood and anxiety disorders developing from loss of the regulatory effects of many of the neurosteroids that are produced in the brain.
11:30 am – 12:00 pm Supplementation for Traumatic Brain Injury – Part I
The major impact of trauma is the production of secondary injury precipitated by free radicals and oxidative stress. The use of specific anti-oxidants and the regeneration of the glutathione system in the brain can help to regain a neuro-permissive environment that can allow for cellular repair and regeneration.
12:00 pm – 1:30 pm Lunch Break
12:00 pm – 1:00 pm  NeuroRegenesis: Treating Memory Loss and the Aging Brain
A.J. Farshchian, M.D.
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Center for Regenerative Medicine
1:30 pm – 2:30 pm Supplementation for Traumatic Brain Injury – Part II
Continuation of the 5th lecture with specific application and treatment of traumatic brain injury. A number of cases will be discussed.
2:30 pm – 3:30 pm Case Studies – Part I
15 comprehensive cases will be dissected and presented with attendees’ participation as a means of consolidating the information that will be shared throughout the day.
2:30 pm Exhibits Open
3:30 pm – 4:10 pm Break / Visit Exhibits
4:10 pm – 5:30 pm Case Studies – Part II
Continuation of the cases with attendee participation and Q & A. The goal of these cases is to allow the audience an opportunity to work out with the lecturer the initial evaluation of the patient, laboratory testing, interpretation of the test results, and selection of an optimal treatment protocol.
5:30 pm – 7:00 pm AMMG Welcome Reception
Open to all conference attendees, spouses, and guests
Held in Conference Networking and Exhibits Center

Friday, November 2nd

General Session Curriculum

Time
Presentation
7:00 am – 7:45 am How Medical Weight Loss and Lipo Laser Can Help Expand Your Age Management Practice
Kimball Lundahl, D.C.
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by Healthy Habits
8:00 am – 8:05 am Opening Remarks
8:05 am – 8:30 am Presentation of the Alan P. Mintz, M.D. Award for Clinical Excellence in Age Management Medicine

 

PROSTATE CANCER

 

Time
Presentation
8:30 am – 9:15 am Upside-down World of Prostate Cancer
Paul Thompson, M.D.
Private Practice, Fort Worth, TX
Everything we thought we knew, and what we think we know now.
9:15 am – 10:00 am Risk Stratification of Men for Prostate Cancer Metastasis and Mortality
Sanoj Punnen, M.D., MAS
Assistant Professor, Dept. of Urology, University of Miami, Miller School of Medicine, Miami, FL
Current prostate cancer screening practices and challenges for early detection of prostate cancer. PSA is sensitive predictor of prostate cancer mortality. PSA ordering practices of primary care physicians. What is a reasonable approach to prostate cancer screening and the validity, safety and effectiveness of a new second stage biomarker test as a follow up test after an abnormal PSA to identify who should (and should not) receive a prostate biopsy. Men with a high risk 4Kscore ≥20% have at least a 1 in 5 chance for having aggressive prostate cancer and should be considered for prostate biopsy. Men with a low 4Kscore <7.5% may safely avoid a prostate biopsy as this infers low risk for high grade disease (Gleason ≥7) at prostate biopsy and prostate cancer related metastasis and death. The presentation will review the relevant peer-reviewed literature on these topics.
10:00 am – 10:30 am Break / Visit Exhibits
10:30 am – 11:15 am MRI-Guided Prostate Laser Ablation for Treatment of Prostate Cancer
Daniel Sperling, M.D.
Medical Director & Chief of Interventional Uroradiology, Sperling Prostate Center, Florida & New York
Medical Director, Sperling Medical Group
With the advent of PSA screening in the mid-1990s, early detection and diagnosis of prostate cancer (PCa) became feasible. Since PCa was held to be a multi-focal disease, a radical treatment approach such as prostatectomy, radiation, or whole gland ablation has been the standard of care. However, radical treatments come with risks of urinary, sexual and bowel comorbidities. Recent clinical developments such as advanced imaging (multiparametric MRI) and genomic analysis now make it possible to identify PCa patients with low-risk disease amenable to either Active Surveillance, with its advantage of deferring treatment while monitoring for disease progression, or focal treatment via thermal ablation, with its advantage of effective cancer control while sparing urinary, sexual and bowel function. One such modality is laser interstitial tumor therapy, or Focal Laser Ablation (FLA). This presentation will explain patient selection for FLA, the mechanism by which FLA destroys tumor tissue, how FLA is delivered, monitored, and verified, and current data on safety and efficacy. It will conclude with the clinical and quality-of-life benefits to the patient.
11:15 am – 12:15 pm A Literature Review of the Controversies in Treating Men with Aromatase Inhibitors: Is Estrogen Good or Bad and Can it Treat Prostate Cancer?
Neal Rouzier, M.D.
Director, The Preventive Medicine Clinics of the Desert, Palm Springs, CA
Recent studies have demonstrated that elevated estrogen (estradiol) levels in men are associated with an increased risk of heart disease. A plethora of data supports this contention. Unfortunately these are only observational studies that do not prove that elevated levels of estrogen cause any increase in harm, rather it is only an association and does not prove causation. In order to prove causation, interventional trials must be done in order to establish causation. There are a multitude of studies that prove high estrogen levels are protective and beneficial and certainly not harmful as we have been falsely mislead to believe. The purpose of this lecture is to review the most recent literature that proves high levels of estradiol are protective against cardiovascular disease, cancer, and osteoporosis. This is in contrast to current recommendations to keep estrogen levels low in men. Various observational studies will be compared to interventional trials to gain a better understanding of the difference in power between the two and the importance of not relying on just observation to prove causation. Observing that high baseline levels of estrogen are harmful in men and extrapolating that to indicate that raising estradiol levels by giving testosterone is also harmful is entirely incorrect and can lead to harm if estrogen is blocked. So much of the beneficial effect of testosterone is in the conversion (aromatization) into estradiol. The importance of estrogen in men will be reviewed as well as the harm of blocking the aromatization into estradiol. No study has ever demonstrated benefit to lowering estrogen levels. Every study demonstrates harm in blocking estrogen aromatization. Unfortunately most physicians remain unaware of this data and continue to prescribe aromatase inhibitors to block estrogen formation. Finally, significant data from the Urologic literature demonstrates the benefit of treating prostate cancer with estrogen, a treatment modality which has been utilized since Huggins used it in the 1940’s. Estrogen does not increase prostate cancer but quite successfully treats it. This review will present these most recent studies.
12:15 pm – 1:30 pm Lunch Break / Visit Exhibits
12:15 pm – 1:15 pm The Spectacular Role of the Human Microbiome in Preventing Metabolic Endotoxemia, the Number One Cause of Mortality Worldwide
Presented by Kiran Krishan, Microbiologist
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Microbiome Labs

 

BREAST CANCER

 

Time
Presentation
1:30 pm – 2:15 pm Estrogen Metabolism, Epigenetics and Breast Cancer Risk
Jennifer Pearlman, M.D., CCFP, NCMP, FAARM, ABAARM, CFA
Pearl MD Center, Toronto, Canada
Affecting hormonal health with vast implications on health, risk of disease and cancer. Explore our innate detoxification system to understand the key steps and determinants of estrogen metabolism that enable the detoxification, inactivation and elimination of endogenous and exogenous estrogens as well as xenoestrogens. Lecture will cover understanding the three phases of innate detoxification, steroidogenic hormonal pathway, estrogen metabolism, genetic determinants of estrogen metabolism, epigenetic factors, nutritional epigenetic factors, environmental exposures, estrogen metabolism errors and breast cancer, functional approach to optimize estrogen metabolism, and a number of clinical cases will be included.
2:15 pm – 3:00 pm DNA Methylation Age is Elevated in Breast Tissue of Healthy Women
Mary E. Sehl, M.D.
Adjunct Associate Professor, UCLA Department of Biomathematics
Our laboratory is interested in accelerated epigenetic aging in breast tissue and the potential role of hormonal factors in driving this acceleration. Using the epigenetic biomarker of aging known as the “epigenetic clock,” limited evidence suggests that female breast tissue ages faster than other parts of the body (Horvath 2013). However, these results were obtained using pooled data mostly based on normal adjacent tissues from breast cancer patients. Using longitudinal data from healthy women who donated both breast and blood tissue to the Susan G. Komen Tissue Bank (KTB) at the Indiana University Simon Cancer Center, we directly compared DNA methylation (DNAm) age of matched breast tissue and peripheral blood in order to validate the accelerated aging effect in breast and explore hormonal factors that could explain the difference. We utilized n=80 breast and 80 matching blood tissue samples collected from 40 healthy women participants in the KTB who donated these samples at two time points spaced at least a year apart. DNA methylation levels were assessed using the Illumina 450K platform. We found that DNAm age was highly correlated with chronological age in both peripheral blood (r=0.94, p<0.0001) and breast tissues (r=0.86, p<0.0001). An age-adjusted measure of intrinsic epigenetic age acceleration was significantly increased in breast relative to peripheral blood tissue (p=1.6 x 10-11). The difference between DNAm age of breast and blood decreased with advancing chronologic age (r=-0.53, p=4.4 x 10-4). Our data demonstrate that female breast tissue has a higher epigenetic age than blood collected from the same subject. The degree of elevation in breast diminishes with advancing age. Further studies are focused on examining associations between epigenetic age acceleration and cumulative hormone exposure.
3:00 pm – 3:30 pm Break / Visit Exhibits
3:30 pm – 4:30 pm FEATURED SPEAKER
Cobalt & Iodine: Effects on Estrogen Metabolism
Jonathan Wright, M.D.
Private Practice, Tahoma Clinic, Tukwila, WA
Cobalt prevents excess urinary excretion of estrogen and testosterone. Cases. Iodine: Effects on Estrogen Metabolism, Fibrocystic Disease, & Breast Cancer. Effects of Iodine, Iodide on E1 àE3 pathway. Iodine eliminates fibrocystic breast disease (the work of John Myers, M.D.) Killing breast cancer cells with Iodo-lactone (research from Mexico, India, Germany).
4:30 pm – 5:30 pm Personalized Medicine Approach for Breast Cancer
Bernard Esquivel, M.D., Ph.D., MHA
President, Latin American Association for Personalized Medicine
To present personalized medicine as a validated evidence-based clinical approach for breast cancer patients.
5:30 pm Reception Introducing AMMG’s Training and Certification in Age Management Medicine
Presentation by Kenneth Janson, M.D.
Open to all conference attendees

Saturday, November 3rd

General Session Curriculum

Time
Presentation
7:00 am – 7:45 am “Compound Your Profits” with Age Management Programs
Dan Powell, Director of Business Development
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by Olympia Compounding Pharmacy

 

Precision Medicine

 

Time
Presentation
8:00 am – 8:45 am FEATURED SPEAKER
Genomics, IPOP and the Predictive Model of Health

Michael Snyder, Ph.D.
Professor and Chair, Department of Genetics, Stanford University School of Medicine, Stanford, CA
Director, Center for Genomics and Personalized Medicine
Recent technological advances as well as longitudinal monitoring not only have the potential to improve the treatment of disease (Precision Medicine) but also empower people to stay healthy (Precision Health). Precision health relies on the ability to detect early preclinical states, predict disease risks at an individual level and initiate preventive strategies. The main goal of this prospective cohort study was to quantify the impact of personalized longitudinal big data on human health. In this context, we enrolled 107 participants that underwent longitudinal integrative Personalized Omics Profiling (iPOP) for up to 8 years (median 2.5 years). Deep molecular profiling was performed quarterly over the study period and included standard clinical, enhanced (i.e.not part of standard clinical care) and emerging (i.e.used for exploratory purposes and mechanistic discoveries) tests. Emerging technologies included genomics, immunomics, transcriptomics, proteomics metabolomics and microbiomics. We discovered at least 45 actionable major health findings spanning various areas including metabolic, cardiovascular and oncology. In addition, we show that the majority of participants made diet and exercise changes due to study participation with the objective of improving their health. We also highlight emerging pathways relevant to diabetes and cardiovascular disease by evaluating the associations between multiomics measurements and standard clinical measures. Altogether, we conclude that deep longitudinal profiling using enhanced and emerging technologies can lead to actionable health discoveries and provide important information relevant for precision health.
8:45 am – 9:30 am Precision Medicine Innovation: Continuous Glucose Monitors for n-of-1 Health Management
Florence Comite, M.D.
CEO & Founder, Comite Center for Precision Medicine, New York, NY
Member, AMMG Conference Planning Committee
Wearables are gamifying medicine, transforming health care into an interactive experience that can reveal our body’s evolving and dynamic biomarkers in real time. By integrating and analyzing longitudinal n-of-1 wearables data — together with an individual’s hormones, metabolomics, genomics, personal and family history, and lifestyle — we can generate a precise understanding of current and future health at the cellular level; and tailor interventions for optimal healthy longevity. This lecture looks specifically at the application of continuous glucose monitors in the clinic, as a powerful and engaging Precision Medicine tool to detect, predict, and reverse diabetes.
9:30 am – 10:15 am Epigenetic Clock Testing – An Accurate, Low Cost Biomarker of Biological Aging
James Watson, M.D.
Clinical Faculty, UCLA Division of Plastic Surgery, David Geffen School of Medicine, Los Angeles, CA
As it turns out, the closest thing that scientists have found in nature that resembles a biological “aging clock” is the age-correlated DNA methylation/demethylation of cytosine DNA bases in human DNA that undergo methylation or demethylation as a function of aging (some of these sites increase in DNA methylation, others undergo a loss of methylation). When these sites are chosen by computer algorithm to create a so-called “aging clock”, the test correlates with chronological age (r = 0.96). Until these “DNA methylation clocks” were invented, no biomarker for biological aging was very accurate at predicting lifespan, mortality, or chronological age based solely on a blood or saliva sample. For instance, the correlation between Telomere length tests and aging is mathematically poor (r =-51 in women, r = -55 inmen). The best biomarker for cellular senescence is not much better (pINK4a expression: r = 0.56). Recently, Steve Horvath and other researchers have used AI-based computer algorithms and the statistical tool called “elastic net regression” to choose specific DNA methylation sites that correlated with aging (Horvath Clock, Hannum Clock, Weidner Clock, etc.) All of these “epigenetic clocks” are all computer-derived and are therefore “agnostic” (no human involvement in the choice of the specific DNA sites occurred). They can be done based on a small blood sample or a saliva sample. They are accurate to within 1-3 years of a person’s chronological age. New clocks are currently being computer-derived that are even more robust and correlate with phenotype much better. These clocks correlate with age-related biological changes much more accurately than the first generation of “epigenetic clocks” (Ex: DNA PhenoAge). A commercially available DNA methylation clock test is available for $300. This test can be ordered by any physician and included in a comprehensive assessment to measure the effect of anti-aging interventions. This lecture will explain the science behind DNA methylation clock testing, how to order and interpret the test results, and what anti-aging interventions have been proven to slow down or reverse the so-called “epigenetic clock”.
10:15 am – 10:45 am Break / Visit Exhibits

 

The Microbiome, Inflammation, and Advanced Endocrinology for Age Management Medicine

 

 

Time
Presentation
10:45 am – 11:30 am Relevance of Gut Microbiota in Gastroenterology Microbiome
Ram Dickman, M.D.
Deputy Head, Division of Gastroenterology, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel
Head, Service of Neurogastroenterology, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel
Chair, Israeli Neurogastroenterology Group, affiliated with the IGA
Councilor, European Society of Neurogastroenterology & Motility (ESNM)
Microbial dysbiosis may represent potential target for therapeutic medical interventions, aimed to change disease course and prognosis of gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Intrinsic and extrinsic factors like genetics, innate immune system, diet, method of infant delivery and breastfeeding, represent additional important pathophysiological factors of these diseases. Recognizing both, the microbial community and these factors, may improve our ability to reduce inflammation in IBD and provide symptom relief in IBS. This presentation will focus on the involvement of gut dysbiosis in IBD, IBS, small intestine bacterial overgrowth (SIBO), and will include a description of our current interventional clinical trials.
11:30 am – 12:15 pm Decoding Stool Test Results Fecal Biomarkers, Commensal Bacteria and Clinical Applications
Non-CME presentation
Lihong Chen, Ph.D
Director of Clinical Research, Genova Diagnostics
In the last couple of decades, our knowledge about the gastrointestinal (GI) system’s role in our overall health has expanded far beyond traditional digestion and absorption functions. We now recognize that the GI tract plays a key role in the development and maintenance of a healthy body and mind. Microbes in the GI tract have the capability of affecting the body’s vitamin and mineral absorbency, hormone regulation, digestion, vitamin production, immune response, ability to eliminate toxins, and overall mental health. With the variety of things that cause great damage to our digestive systems and gut microorganisms, the GI tract can be the root cause of many health issues affecting modern society.
The GI tract is important to our health, whether or not we have GI symptoms, although GI symptoms can be the primary reason that many patients seek medical attention. Other common chronic diseases/conditions such as autoimmune diseases, mood disorders (e.g. anxiety and depression), and metabolic and cardiovascular diseases (e.g. diabetes, obesity, fatty liver/non-alcoholic steatohepatitis, and atherosclerosis) are all strongly associated with root causes in the GI tract. The GI tract plays a pivotal role in the development and regulation of the body’s entire immune system. In addition, the gut-brain connection is critical for regulating the hormonal-neuronal system. Therefore, the health of the GI system is extremely important to our overall well-being. A stool test measures a group of biomarkers and commensal bacteria. The test can reveal important information about the health of the GI system, including inflammation, digestion/absorption, and homeostasis of the microbiome. It may also reveal root causes of many common gastrointestinal symptoms and conditions that are associated with systemic abnormalities. In the current project, we analyzed a data set of stool tests from 173,221 patients to identify associations and patterns among biomarkers and commensal bacteria and generate comprehensive profiles and fingerprints for different GI health conditions. We confirmed previously published GI profiles. Other new profiles were developed by analyzing a large number of patients’ test results. We believe that these unique patterns of test results are required for evidence-based, accurate, and personalized intervention.
12:15 pm – 1:30 pm Lunch Break / Visit Exhibits

Complimentary attendee lunch provided by AMMG exhibitors
Served in the Exhibit Hall

1:30 pm – 2:30 pm Impact of Microbiome in Advanced Endocrinology
Dushyant Viswanathan, M.D., ABIM, ABoIM, AACE
Medical Director, The Columbia Center for Integrative Medicine, Columbia, MD and Woodland Hills, CA
Dysbiotic gut inflammation leads to high endogenous demand for cortisol over time, which in turn leads to decreases in beneficial steroid hormone levels (as a result of shunting of steroid hormone precursors into generation of cortisol) and increases risk for hypothyroidism. The metabolic consequences of this pathophysiology is here offered as the underlying cause of chronic inflammatory and degenerative conditions that age management physicians routinely encounter in their patients. In this presentation substantiating data for this model is presented, as well as updates of our clinical trial measuring the impact of microbiome and endocrine balancing strategies on hemoglobin A1C. Specific cases presentations will be made featuring a range of pathologies relevant to age management physicians: prostate cancer, chronic fatigue, chronic painful polyarthropathy, cognitive impairment, and type 2 diabetes.
VISWANATHAN, D – Lecture References
2:30 pm –3:10 pm Clinical Yogatherapy & Integrative Alchemy for Gut Dysbiosis Causing Chronic Inflammation Leading to Endocrine Disorders
Elaina Heather Viswanathan, RYT
Director of Holistic Healing, The Columbia Center for Integrative Medicine, Columbia, MD and Woodland Hills, CA
Holistic approaches that will be discussed include the use of essential oils, medical yogatherapy, seed cycling, mudra, and meditation to optimize emotional processing, balance the autonomic nervous system, and promote hormone balancing. We will discuss specific cases of chronic pelvic pain syndrome, prostate cancer, endometriosis, SIBO, anxiety, and depression.
VISWANATHAN, E H – Lecture References
3:10 pm – 3:45 pm Break / Visit Exhibits (exhibits close 3:45pm)
3:45 pm – 5:00 pm The Gut-Brain Continuum Revelations on Microbiome in the the Neuroendocrine System
Zach Bush, M.D.
Founder & Medical Director, M Clinic, Charlottesville, VA
CEO, Seraphic Group, Inc., Charlottesville, VA
The beginning of health is increasingly understood to involve the myriad of relationships between the Gut-Brain systems. The continued development of our understanding of the microbiome and its direct and indirect roles on the anatomy and function of the neuroendocrine function of the intestinal lining has revealed the microbiome as ground zero for health and disease. Here we look at the environmental threats and the microbiome defense systems for resilient barriers to protect the immunologic systems of the immune systems of the peripheral and central nervous system, and point to practical methods for you and your patients to preserve genomic health through reconnection with our environment.
5:00 pm – 5:30 pm Microbiome Q & A
Zach Bush, M.D.
Dushyant Viswanathan, M.D.
Ram Dickman, M.D
Elaina Heather Viswanathan, RYT
5:30 pm – 6:30 pm Lecture Follow-up: Meet Dr. Jonathan Wright
Additional information not included in Friday’s lecture will be presented.
Held in San Ignacio Room – open to all attendees

Sunday, November 4th

General Session Curriculum

Time
Presentation
7:00 am – 7:45 am Risk Avoidance: A Malpractice Report – Real Physicians & Real Lawsuits
John Rush, M.D., Chairman & CEO, Longevity Physicians Insurance Company
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by Longevity Physicians Insurance Company

 

Time
Presentation
8:00 am – 9:30 am Clinical Case Review, Discussion and Recommendations for Individualized Treatment Plans on Cases Submitted by Attendees
Panel 1:
Michale Barber, M.D.
CEO, CMO, Better Life Carolinas, Charleston, SC
Paul Thompson, M.D.
Private Practice, Fort Worth, TX
Neal Rouzier, M.D.
Director, The Preventive Medicine Clinics of the Desert, Palm Springs, CA
Discussion of actual clinical cases by experienced physicians with years of experience in this field is critical to the educational process for Age Management Medicine. Prior to the conference attendees were asked to submit cases for discussion during this session. Our Planning Committee selected those cases that we feel are educationally important, informative and present significant information for discussion. AMMG encourages interactive discussion between the panel and members of our audience
Get details for submission.
Please submit your case(s) using the submission form. When completed, email your submission form to: MBrown@agemed.org or fax to: 630-429-9500.
9:30 am – 11:00 am Clinical Case Review, Discussion and Recommendations for Individualized Treatment Plans on Cases Submitted by Attendees
Panel 2:
Florence Comite, M.D.
CEO & Founder, Comite Center for Precision Medicine, New York, NY
Member, AMMG Conference Planning Committee
John K. Crisler, D.O.
President, Founder & CMO, Superior Age Management, AllThingsMale Center for Men’s Health, Lansing, MI
Dept. of Community & Family Medicine, Michigan State University College of Osteopathic Medicine, East Lansing, MI
George Shapiro, M.D.
Adjunct Assistant Professor Clinical Medicine, New York Medical College, Valhalla, NY
Founding Partner, Cenegenics, New York City
Member, AMMG Conference Planning Committee
Kathy Maupin, M.D.
Owner & President, BioBalance Health, St. Louis, MO
Discussion of actual clinical cases by experienced physicians with years of experience in this field is critical to the educational process for Age Management Medicine. Prior to the conference attendees were asked to submit cases for discussion during this session. Our Planning Committee selected those cases that we feel are educationally important, informative and present significant information for discussion. AMMG encourages interactive discussion between the panel and members of our audience
Get details for submission.
Please submit your case(s) using the submission form. When completed, email your submission form to: MBrown@agemed.org or fax to: 630-429-9500.
11:00 am – 11:30 am Break
11:30 am – 12:30 pm Neglected But Effective Therapies Part 1 (General Issues)
Jonathan Wright, M.D.
Private Practice, Tahoma Clinic, Tukwila, WA
Reducing risk of heart attack and stroke by 45%-88%, reduce risk of type 1 diabetes by 80%, eliminate colds and flu in 3 days or less, permanently eliminate gallbladder attacks & avoid surgery, elimination of childhood “bedwetting” in 80% of cases, the cause of and (therefore) total prevention of strep throat, inverse relationship between serum vitamin D and “all-cause mortality”, complete control of osteoarthritis symptoms in 90% or more of cases, acne rosacea, cause and natural cure, and other research-based, effective but neglected natural therapies
12:30 pm – 1:30 pm Neglected But Effective Therapies Part 2 (Women’s Health Issues)
Jonathan Wright, M.D.
Private Practice, Tahoma Clinic, Tukwila, WA
Gestational diabetes cured in 90+% of women within two weeks, preventing and (if necessary) reversing toxemia of pregnancy, elimination of nausea and vomiting of pregnancy in 92% of sufferers within 3 days, elimination/major improvement in menorrhagia in 92% of afflicted women, safe, natural cure for endometriosis, estrogen and women’s lung function, positive effects of DHEA on women’s sexual function, which foods promote faster skin wrinkling, which ones don’t, retarding skin wrinkling significantly with microdose topical applications of hormones. Treatment and potential cure for auto-immunity in women: HCG and estriol, major improvement in multiple sclerosis with estriol, and other research-based, effective but neglected therapies.